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ABSTRACT 
 
The high genetic diversity and rapid evolution of HIV-1 poses a challenge to the worldwide 
prevention and treatment programs. Effective antiretroviral treatment has significantly improved the 
quality of life for HIV-infected patients. However, it came with a cost because resistant viruses 
emerge and sometimes are transmitted, which can reduce the efficacy of first-line antiretroviral 
therapy. Sequencing of the HIV-1 genome can provide information on both viral diversity and 
antiretroviral resistance profiles. This thesis work investigated HIV-1 resistance and molecular 
epidemiology in Honduras. 
In paper I the prevalence of antiretroviral drug resistance was investigated in 138 HIV-positive 
Honduras patients with signs of treatment failure by partial sequencing of the HIV-1 pol gene. The 
prevalence of antiretroviral resistance was high and resistance mutations were detected in 112 
patients (81%). Virologic failure was the strongest predictor of treatment failure and poor access to 
viral load testing in Honduras was identified as an important problem. Paper II investigated 
transmitted drug resistance in a representative sample of 200 treatment-naïve, newly diagnosed 
Honduran HIV-1 patients. The prevalence of transmitted drug resistance was 7%: 5% for NNRTI, 3% 
for NRTI and 0.5% for PI. Recent infection, as determined by the serological BED assay, was observed 
in 12% of the patients and was associated with a higher prevalence of transmitted drug resistance.   
Little is known about how HIV-1 has entered and spread in Honduras and Central America. In 
paper III the molecular epidemiology of HIV-1 in Honduras was investigated using pol gene sequences 
from a representative sample of 257 Honduran patients. The Honduran HIV-1 epidemic was found to 
be dominated by six subtype B clades that were introduced into Honduras between 1966 and 1984. 
One HIV-1 clade has been particularly successful and accounts for 64% of the current HIV-1 cases in 
the country. The analyses suggested that HIV-1 was introduced into Honduras from the United States 
of America. In paper IV phylogenetic analyses were also used to understand the spread of HIV-1 in 
Central America using 625 HIV-1 pol gene sequences collected between 2002 and 2010 in Belize, 
Costa Rica, El Salvador, Honduras, Nicaragua and Panama. Published sequences from neighboring 
countries (n=57) and the rest of the world (n=740) were included as controls. Maximum-likelihood 
analyses showed that almost all (98.9%) sequences were of subtype B and that 436 (70%) sequences 
formed five significantly supported, monophyletic clades, which almost exclusively contained Central 
American sequences. One clade contained 386 (62%) sequences from all six countries; the other four 
clades were more country-specific, suggesting a compartmentalized epidemic. Bayesian coalescent-
based methods were used to time the HIV-1 introductions and showed that the most recent common 
ancestor of the main subtype B introductions into Central America dated back to 1960-1970’s. 
In conclusion, this thesis highlights the importance of drug resistance surveillance in treated and 
untreated patients, and points to a need for increased access and use of HIV testing, CD4 counts, viral 
load and resistance testing in Honduras. Understanding the factors responsible for the HIV-1 
epidemic in Honduras and Central America has important implications in terms of intervention and 
control strategies. 
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